摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,1'S,3aS,3'aS,5aS,5'aS,6R,6'R,11bR,11'bR,11cR,11'cR)-11,11'-(methylenbis(oxy))bis(3-benzyl-14-(cyclopropylmethyl)-3a-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one) | 1550230-22-2

中文名称
——
中文别名
——
英文名称
(1S,1'S,3aS,3'aS,5aS,5'aS,6R,6'R,11bR,11'bR,11cR,11'cR)-11,11'-(methylenbis(oxy))bis(3-benzyl-14-(cyclopropylmethyl)-3a-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one)
英文别名
——
(1S,1'S,3aS,3'aS,5aS,5'aS,6R,6'R,11bR,11'bR,11cR,11'cR)-11,11'-(methylenbis(oxy))bis(3-benzyl-14-(cyclopropylmethyl)-3a-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one)化学式
CAS
1550230-22-2
化学式
C61H68N4O10
mdl
——
分子量
1017.23
InChiKey
ZCNJRFRHURWMIW-HWWXVGNFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.23
  • 重原子数:
    75.0
  • 可旋转键数:
    14.0
  • 环数:
    16.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    142.94
  • 氢给体数:
    2.0
  • 氢受体数:
    12.0

反应信息

  • 作为产物:
    描述:
    (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one二溴甲烷potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 15.0h, 以66%的产率得到(4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-(cycloprpylmethyl)-1-methoxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one
    参考文献:
    名称:
    Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure
    摘要:
    We synthesized compounds 4a,c-f,h,i containing the oxazatricyclodecane structure from a novel rearrangement reaction product 2a. All the prepared compounds 4a,c-f,h,i exhibited full agonistic activities for the delta opioid receptor (DOR). Among them, the N-methyl derivative 4c was highly selective, and the most effective DOR agonist in functional assays. Subcutaneous administration of 4c produced dose-dependent and NTI (selective DOR antagonist)-reversible antinociception lacking any convulsive behaviors in the mice acetic acid writhing tests. The N-methyl derivative 4c is expected to be a promising lead compound for selective DOR agonists with a novel chemotype.
    DOI:
    10.1021/ml400491k
点击查看最新优质反应信息